期刊
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
卷 51, 期 3, 页码 443-449出版社
ELSEVIER
DOI: 10.1016/j.ijantimicag.2017.11.013
关键词
Augmented renal clearance; Therapeutic failure; beta-Lactams; Sepsis; Critical illness
This study assessed whether augmented renal clearance (ARC) impacts negatively on antibiotic concentrations and clinical outcomes in patients treated by high-dose beta-lactams administered continuously. Over a 9-month period, all critically ill patients without renal impairment treated by one of the monitored beta-lactams for a documented infection were eligible. During the first 3 days of antibiotic therapy, every patient underwent 24-h CLCr measurements and therapeutic drug monitoring. The main outcome was the rate of beta-lactam underdosing, defined as a free drug concentration < 4 x MIC of the known pathogen. Secondary outcomes were rates of subexposure for beta-lactams and therapeutic failure. The performance of CLCr in predicting underdosing was assessed by a ROC curve, and multivariable logistic regression was performed to determine risk factors for subexposure and therapeutic failure. A total of 79 patients were included and 235 samples were analysed. The rate of underdosing(<4xMIC) was 12%, with a significant association with CLCr (P < 0.0001). A threshold of CLCr >= 170 mL/min had a sensitivity and specificity of 0.93 (95% CI 0.77-0.99) and 0.65 (95% CI 0.58-0.71) for predicting beta-lactam underdosing(<4xMIC). Mean CLCr values >= 170 mL/min were significantly associated with subexposure(<4xMIC) [OR = 10.1 (2.4-41.6); P = 0.001]. Patients with subexposure(<4xMIC) presented higher rates of therapeutic failure [OR = 6.3 (1.2-33.2); P = 0.03]. Mean CLCr values >= 170 mL/min remain a risk factor for subexposure to beta-lactams despite high doses of beta-lactams administered continuously. beta-Lactam subexposure was associated with higher rates of therapeutic failure in septic critically ill patients. (C) 2017 Elsevier B.V. and International Society of Chemotherapy. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据